Clinical Trials Browser

Phase 3 × Terminated × 30 days × Clear all

Carcinoma, Non-Small-Cell Lung

NCT01507506 2026-04-14

SPECTRO GLIO

Phase 3 Terminated

180 enrolled

CNS

Glioblastoma

NCT01366612 2026-04-03

FLUBUTBI

Phase 3 Terminated

53 enrolled 11 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

NCT04251533 2026-04-03

EPIK-B3

Phase 3 Terminated

137 enrolled 21 charts

Breast

Triple Negative Breast Neoplasms

NCT05009290 2026-04-03

A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy

Phase 3 Terminated

391 enrolled

Genitourinary

Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy

NCT05937672 2026-04-03

Cold Atmospheric Plasma Device Extension Study

Phase 3 Terminated

60 enrolled

Molluscum Contagiosum, Warts

NCT03085004 2026-03-30

CHARM

Phase 3 Terminated

75 enrolled

Gastrointestinal

Pancreatic Cyst

NCT04689594 2026-03-27

A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk Group

Phase 3 Terminated

1 enrolled

Gastrointestinal

Superficial Esophageal Cancer

NCT04338269 2026-03-19

CONTACT-03

Phase 3 Terminated

522 enrolled 22 charts

Genitourinary

Carcinoma, Renal Cell

Clinical Trials

Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer

SPECTRO GLIO

FLUBUTBI

EPIK-B3

A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy

Cold Atmospheric Plasma Device Extension Study

CHARM

A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk Group

CONTACT-03